The Harvard Stem Cell Institute (HSCI) invites applications for seed grants funding. The purpose of this program is to provide early funding for innovative projects in the field of stem cell research including basic, translational and clinical research.... Read more about HSCI invites applications for seed grants
HSCI Principal Faculty member Konrad Hochedlinger, PhD, received the ISSCR Outstanding Young Investigator Award at the ISSCR 7th Annual Meeting in Barcelona. The award, which recognizes the exceptional achievements of an investigator in the early part of his or her independent career in stem cell research, includes a $7,500 personal award and complimentary registration to the ISSCR Annual Meeting where he was honored.
HSCI investigators at MGH will now have expedited access to mouse models made by the Genome Modification Facility (GMF). This is what Steven Niemi, DVM, Director of the Center for Comparative Medicine (CCM) at MGH announced in a recent email after completing an extensive review of the pathogen monitoring process at the Harvard facilities and the GMF. By adopting the Express Quarantine process, MGH will move GMF mice into their barrier facilities by 6 weeks of age, which effectively will eliminate any delays in setting up research colonies.